Avantor, Inc.

$11.89

+$0.43 (+3.75%)

Jan 5, 2026

Price History (1Y)

Analysis

Avantor, Inc. is a healthcare company in the medical instruments and supplies industry with a significant presence, employing 13,500 people. The company's market capitalization stands at $8.11 billion. The company's financial health shows mixed results. Avantor has a gross margin of 33.1% but an operating margin of 8.5%, indicating some level of operational efficiency. However, the profit margin is negative at -1.2%. In terms of returns, Avantor generates a return on assets (ROA) of 3.4%, but its return on equity (ROE) is negative at -1.5%. The company's balance sheet shows a significant amount of debt, with a debt-to-equity ratio of 69.26, and relatively low cash reserves at $251.90 million. Avantor's valuation metrics include a forward price-to-earnings (P/E) ratio of 13.05, which is lower than the industry average. The company's revenue growth has been declining over the past year, with a rate of -5.3%. Dividend information is not available, as indicated by an N/A value for both dividend yield and payout ratio.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Avantor, Inc.

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Visit website →

Key Statistics

Market Cap
$8.11B
P/E Ratio
N/A
52-Week High
$23.32
52-Week Low
$10.62
Avg Volume
10.70M
Beta
0.93

Company Info

Exchange
NYQ
Country
United States
Employees
13,500